A molecular diagnostics company developing novel blood-based early detection and disease monitoring tests based on analyzing circulating cell-free messenger RNA (cf-mRNA) in blood samples to monitor organ function.
Molecular Stethoscope is based in San Diego, California and was founded in 2015 by Stephen Quake and Eric Topol. Quake is a Professor of Bioengineering at Stanford University and co-president at the Chan Zuckerberg Biohub, he developed the first non-invasive prenatal test for Down Syndrome and other aneuploidies. Topol is the Executive Vice President of the Scripps Research Institute and the Founder and Director of Scripps Translational Science Institute, La Jolla, California.
Molecular Stethoscope raised a total of $8.2M in Seed round funding completed in January 2017. Investors taking part in the round include Pfizer, Data Collective DCVC, and Index Ventures.